Open an account

Aurora Cannabis

ACB · TORONTO

$3.88−$0.09 (−2.27%)TodayMarket closed ·
Prev close $3.97

About ACB

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.

Employees
1,101
Headquarters
Leduc, British Columbia
Listed
Sep 26, 2007
Sector
Health Care
Industry
Pharmaceuticals
Website
auroramj.com

ACB key statistics

Market cap
366.86M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.12M
Volume
602.93K
Open price
$3.96
High today
$3.96
Low today
$3.87
52 Week high
$6.36
52 Week low
$2.56

Aurora Cannabis (ACB) at a glance

As of Oct 23, 2026, Aurora Cannabis (ACB) shares are priced at $3.88, giving the company a market cap of 366.86M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.87 and $3.96. The current price is 0.3% above the day's low and 2.0% below its high.

Volume so far is 602.93K shares, below the average of 1.12M shares a day.

Over the past year Aurora Cannabis has ranged from $2.56 to $6.36, and now sits 35% of the way up that range.

Aurora Cannabis met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported -$0.07 per share against an estimate of -$0.2559.

ACB earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 878.9% on average.

  1. Q1 FY25: reported $0.13 per share against an estimate of -$0.1885
  2. Q2 FY25: reported -$0.22 per share against an estimate of -$0.1044
  3. Q3 FY25: reported $0.58 per share against an estimate of $0.0126
  4. Q4 FY25: reported -$0.44 per share against an estimate of $0.1347
  5. Q1 FY26: reported $0.11 per share against an estimate of -$0.0859
  6. Q4 FY26: reported $0.11 per share against an estimate of -$0.0859
  7. Q1 FY27: reported -$0.07 per share against an estimate of -$0.2559
  8. Q2 FY26: reported -$0.07 per share against an estimate of -$0.2559

ACB news

  • Vandana Singh

    Curaleaf Demands Engagement From Aurora Amid Fierce Acquisition Dispute

  • Press releasePRNewswire

    Aurora Cannabis Reaffirms Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside

  • Press releasePRNewswire

    Aurora Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output

  • Press releasePRNewswire

    Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway

  • Press releasePRNewswire

    Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid

  • Press releasePRNewswire

    Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure

  • Press releasePRNewswire

    Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond

  • Press releasePRNewswire

    Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts

Similar companies

Companies in the same industry as Aurora Cannabis

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.